Company Eastgate Biotech Corp. Other OTC
Equities
ETBI
US2772531008
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Natural Compounds and Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15/15/15 |
William Abajian
PSD | President | 66 | 01/16/01 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12/17/12 |
Anna Gluskin
BRD | Director/Board Member | 68 | 22/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22/12/22 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15/15/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,257,377 | 717,257,377 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+50.03% | 781B | |
-7.10% | 350B | |
+18.55% | 330B | |
+7.49% | 293B | |
+16.91% | 248B | |
+0.53% | 221B | |
+11.06% | 217B | |
+3.58% | 162B | |
-3.80% | 157B |